Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 21 April 2006:
Vol. 312. no. 5772, pp. 382 - 383
DOI: 10.1126/science.312.5772.382
Prev | Table of Contents | Next

News

Oseltamivir Becomes Plentiful--But Still Not Cheap

Martin Enserink

The shortage of oseltamivir may soon be a thing of the past. But whether the drug will become cheap enough for developing countries and how well it will work against a pandemic remain to be seen.(read more.)

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Systematic Review: Safety and Efficacy of Extended-Duration Antiviral Chemoprophylaxis Against Pandemic and Seasonal Influenza.
N. Khazeni, D. M. Bravata, J.-E. C. Holty, T. M. Uyeki, C. D. Stave, and M. K. Gould (2009)
Ann Intern Med 151, 464-473
   Abstract »    Full Text »    PDF »
From the Library.
(2006)
Br J Ophthalmol 90, 930
   Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)